How big is the Immunohistochemistry Market?
According to 6Wresearch internal database and industry insights, the
Global Immunohistochemistry Market was valued at USD 1.8 Billion in 2024 and is expected to reach USD 2.61 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The market is expanding due to increased cancer diagnostics, biomarker discovery, and demand for targeted therapeutic solutions.
Key Growth Drivers of the Immunohistochemistry Market
- Increasing cancer prevalence driving the need for diagnostic testing
- Rising demand for personalized medicine and targeted therapies
- Technological advancements in antibody development and staining
- Growth in aging population and chronic disease prevalence
- Expanding adoption in pathology labs and research institutes
Immunohistochemistry Market Trends
The immunohistochemistry market is evolving with growing integration of digital pathology and AI-based analysis tools that streamline tissue image interpretation. Automation of IHC staining platforms enhances reproducibility and efficiency. Multiplex IHC techniques enabling simultaneous detection of multiple biomarkers are gaining traction. There's also an increasing focus on standardized assay kits for clinical use and research reproducibility.
Emerging Developments in the Immunohistochemistry Market
New antibody clones increasing the sensitivity and specificity represent the growth trends of the Immunohistochemistry Market. Organizations are investing in cloud-based platforms of remote diagnostic and image sharing. Predictive histopathology is being used by emerging startups. The Biopharma firms are partnering diagnosis labs to come up with companion diagnosis. There is also emerging interest in expansion of IHC application in Disease research.
Major Companies in the Immunohistochemistry Market
- F. Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Cell Signaling Technology, Inc.
- Abcam plc
- PerkinElmer Inc.
- BioCare Medical, LLC
- Enzo Biochem, Inc.
How big is the Immunohistochemistry Market : FAQ's
It was valued at USD 1.8 Billion in 2024 and is projected to reach USD 2.61 Billion by 2031.
The immunohistochemistry market is expected to grow at a CAGR of 5.60% from 2025 to 2031.
Growth in cancer cases, demand for biomarker testing, and lab automation solutions.
Used in cancer diagnosis, drug testing, biomarker identification, and neuroscience.
North America leads due to robust healthcare infrastructure and R&D investments.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com